← All stocks

NovoCure Ltd

NVCR No buying or selling
CIK 0001645113 #2023 in the set updated 18 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
$0.00
$0.00 against sales at will

By person

18 insiders · 0 transactions
14.5×

Frank Leonard holds 14.5 times base salary in stock. $8.27M of shares against $570.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Frank Leonard last reported holding, valued at $17.93, the price Ordinary Shares was last bought or sold at on the open market here, on 4 Jun 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Leonard Frank X
Chief Executive Officer
461,425
$8.27M
+185.1%
Cordova Ashley
Former Chief Executive Officer
422,570
$7.58M
+92.8%
Danziger Asaf
Director
416,742
$7.47M
+2,637%
DOYLE WILLIAM F
Executive Chairman
328,397
$5.89M
Weinberg Uri
Chf Medical and Innovation Ofr
267,190
$4.79M
+56.1%
Ben Arye Barak
General Counsel
243,752
$4.37M
+106.3%
VERNON W ANTHONY
Director
209,267
$3.75M
+23.9%
Puri Michal Nath
Chief Human Resources Officer
203,227
$3.64M
+83.2%
Brackmann Christoph
Chief Financial Officer
182,842
$3.28M
+176.3%
Leupin Nicolas
Former Chief Medical Officer
102,979
$1.85M
+101.4%
LEUNG GABRIEL
Director
101,109
$1.81M
+23.0%
Paravasthu Mukund
Chief Operating Officer
72,832
$1.31M
+1,888%
Hung David
Director
32,075
$575.22K
+143.1%
Madden Martin J.
Director
30,284
$543.10K
+53.9%
Scannell Timothy J
Director
25,898
$464.44K
+269.1%
HILLEMAN JERYL L
Director
25,471
$456.78K
+286.5%
Stafford Kristin
Director
22,934
$411.29K
+465.9%
Ocean Allyson J
Director
22,934
$411.29K
+465.9%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 0
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 6 Dec 2016